R Squared’s Usana Health Sciences USNA Stock Holding History

R Squared’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-790	Closed	-$28.4K	–	1471
2024 Q4	$28.4K	Buy	+790	New	+$29.5K	0.03%	735

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

R Squared's USNA Position: Q1 2025 in Review

R Squared sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 790 shares — an estimated $28.4K sold.

R Squared first reported a position in USNA in Q4 2024 and held it in 1 quarter. The position peaked at $28.4K in Q4 2024. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

R Squared reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
R Squared sold 790 Usana Health Sciences shares in Q1 2025, an estimated $28.4K.
R Squared first reported a position in Usana Health Sciences in Q4 2024 and held it in 1 quarter.
R Squared's Usana Health Sciences position peaked at $28.4K in Q4 2024.
162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.